Suppr超能文献

心脏移植受者感染的频率及其与急性排斥反应发作的关系。

Frequency of infections and their relation to episodes of acute rejection among heart allograft recipients.

作者信息

Lemström K, Koskinen P, Lautenschlager I, Krogerus L, Nieminen M, Häyry P, Mattila S

机构信息

Transplantation Laboratory, University of Helsinki, Finland.

出版信息

Presse Med. 1994 Sep 17;23(27):1252-6.

PMID:7971859
Abstract

OBJECTIVES

Infections and episodes of acute rejections are major factors affecting allograft survival during the first year after transplantation. The frequency of infections, and the relation of injections to rejection episodes were studied among heart allograft recipients with the follow-up time one year.

METHODS

The study population consisted of 58 patients receiving a heart allograft through 1985 to 1990. Low-dose triple-drug therapy was used for immunosuppression, and rejections were treated either with methylprednisolone, antithymocyte globulin, or the combination of methylprednisolone and antithymocyte globulin. The patients received 2 g of vancomycin i.v. 2 days postoperatively, and no further antibacterial prophylaxis was used. The diagnosis of infection was based on clinical symptoms and on microbiological or serological demonstration of an infection. When the correlations between severe infections and rejections were examined, only infections occurring within 1 month from the onset of the rejection were included. Chi-square test was used for statistical analysis.

RESULTS

Seventy-nine infections were registered (1.6 +/- 1.4 episodes/patients); 74% of the patients underwent at least one infection episode. Most infections, 61% (49), occurred during the first three posttransplant months, cytomegalovirus and bacterial agents accounting for the most important aetiology. No difference in the overall infection frequency existed between the patients with or without rejections. Twenty seven infection episodes were recorded in 18/50 patients with rejections (p = NS), 11 of them in relation to rejection in 5/18 patients. The frequency of infections after antirejection therapy either with antithymocyte globulin or the combination of methylprednisolone and antithymocyte globulin (7/11) was higher than with methylprednisolone alone (4/20) (p < 0.05). Infections were the primary cause of death in 50%. The rest of deaths were caused by acute rejections.

CONCLUSION

There was a typical pattern of infections occurring mainly during the first three months after transplantation, and a significant tendency towards severe infections after intense antirejection therapy with antithymocyte globulin.

摘要

目的

感染和急性排斥反应是影响移植后第一年同种异体移植物存活的主要因素。本研究对心脏同种异体移植受者随访一年,观察感染的发生频率以及感染与排斥反应发作之间的关系。

方法

研究对象为1985年至1990年间接受心脏同种异体移植的58例患者。采用低剂量三联药物疗法进行免疫抑制,对于排斥反应,使用甲泼尼龙、抗胸腺细胞球蛋白或甲泼尼龙与抗胸腺细胞球蛋白联合治疗。患者术后第2天静脉注射2g万古霉素,术后不再使用其他抗菌预防措施。根据临床症状以及微生物学或血清学检查结果诊断感染。在检查严重感染与排斥反应之间的相关性时,仅纳入排斥反应发作后1个月内发生的感染。采用卡方检验进行统计分析。

结果

共记录到79次感染(1.6±1.4次/患者);74%的患者至少经历过一次感染发作。大多数感染(61%,即49次)发生在移植后的前三个月,其中巨细胞病毒和细菌是最重要的病因。有排斥反应和无排斥反应的患者在总体感染频率上没有差异。50例有排斥反应的患者中有18例记录到27次感染发作(p=无显著性差异),其中5/18例患者的11次感染发作与排斥反应有关。使用抗胸腺细胞球蛋白或甲泼尼龙与抗胸腺细胞球蛋白联合进行抗排斥治疗后的感染频率(7/11)高于单独使用甲泼尼龙后的感染频率(4/20)(p<0.05)。感染是50%患者的主要死亡原因。其余死亡由急性排斥反应导致。

结论

感染具有典型的发作模式,主要发生在移植后的前三个月,并且在使用抗胸腺细胞球蛋白进行强化抗排斥治疗后,发生严重感染的倾向显著增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验